-
GlaxoSmithKline Will Revise “Black-box” Warning On Its Asthma Drugs Advair And Serevent
Novartis, However, Continues To Disagree With FDA About The Need To Change Label On Foradil GlaxoSmithKline has finally agreed with the FDA to revise a "black-box" warning on its asthma medications Advair and Serevent…
-
March 2006 FDA “Patient Safety News” Videos For Doctors Online
Edition Covers Tamiflu, Paxil, Avandia, Amicar and Omacor Name Confusion, and More The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for doctors and other health care…
-
Two Studies Link Antibiotic Tequin To Side Effects That Can Be “Life Threatening”
NEJM Editorial Urges "Black-box" Warning For Tequin, And Suggests That This Antibiotic Should Be Recalled On March 1, 2006 The New England Journal of Medicine released early an article about two Canadian studies concerning…
-
FDA Reviewing Safety Of Bayer’s Heart Surgery Drug Trasylol
Studies Link Trasylol To Kidney Problems, Heart Attacks, and Strokes In mid-February 2006 the FDA issued a Public Health Advisory informing doctors and patients that the agency was evaluating the safety of Bayer AG’s…
-
FDA and Health Canada Issue Warnings For Antibiotic Tequin
Advising Diabetic Patients Not To Use Tequin Due To Concerns About Blood Sugar Disorders In mid-February 2006 the FDA and Health Canada issued separate alerts regarding the threat of rare but potentially fatal side…
-
Adderall and Ritalin: With Heart Risks Uncertain, What Should Patients Do?
Some Medical Advice About ADHD/ADD Drugs From Cardiologists And Psychiatrists In mid-February 2006 came the news that an advisory panel of drug-safety experts recommended a "black-box" warning for Adderall, Ritalin, and the other ADHD/ADD…
